Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits

Systemic absorption of ocularly administered Brimonidine Tartrate has been reported to give rise to several side-effects. Hence, it has become crucial to develop a delivery system that could increase efficacy and reduce systemic absorption. Therefore, the present work aims to develop Brimonidine Tar...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical development and technology Vol. 23; no. 3; p. 231
Main Authors Pang, Xiaochen, Li, Jiawei, Pi, Jiaxin, Qi, Dongli, Guo, Pan, Li, Nan, Wu, Yumei, Liu, Zhidong
Format Journal Article
LanguageEnglish
Published England 16.03.2018
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Systemic absorption of ocularly administered Brimonidine Tartrate has been reported to give rise to several side-effects. Hence, it has become crucial to develop a delivery system that could increase efficacy and reduce systemic absorption. Therefore, the present work aims to develop Brimonidine Tartrate gels with different concentrations (0.05%, 0.1%, and 0.2% w/v, respectively) using Carbopol 974 P and HPMC E4M, and compare the therapeutic efficacy and systemic absorption with that of eye drop (0.2%, w/v) by UPLC-MS/MS. The result of histological analysis did not show any morphological or structural changes after the administration of formulations. In vitro residence time studies demonstrated that the gels exhibited a better precorneal residence time as compared with the eye drop. The gels with lower concentrations of the drug (0.05% and 0.1%, w/v) could significantly decrease intraocular pressure (IOP) in both normal and water-loaded rabbits as compared to the eye drop. Finally, the values of the ratio of AUC in comparison to eye drop showed the gels with lower concentrations of Brimonidine Tartrate could decrease the systemic absorption. From the result, it can be concluded the 0.1% ophthalmic gel has a potential to improve therapeutic efficacy and reduce the potential toxicity caused by systemic absorption.
ISSN:1097-9867
DOI:10.1080/10837450.2017.1328693